Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog

CureSearch for Children's Cancer

CharityWatch report issued
November 2022

B+
CharityWatch Grade
Our independent grade based
on a number of factors.
 
74%
Program Percentage
Amount spent on programs
relative to overhead.
 
$25
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

CureSearch for Children's Cancer
PO Box 45781
Baltimore, MD 21297-5781

Other Names

CureSearch
National Childhood Cancer Foundation/NCCF--(formerly known as)

Tax Status

501(c)3

Stated Mission

To fund and support targeted and innovative cancer research with measurable results, and to be the authoritative source of information and resources for all those affected by children's cancer.

View similar charities
Charity  
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America (DISSOLVED)  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Research Institute  
Cancer Survivors' Fund  
CancerCare  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation (DISSOLVED)  
Children's Cancer Research Fund  
Children's Leukemia Research Association  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation / Stand Up To Cancer  
Good Charity (DISSOLVED)  
Leukemia & Lymphoma Society  
Livestrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Breast Cancer Foundation  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 12/31/2021

Program Percentage: 74%

The percentage of CureSearch for Children's Cancer's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).

$4,800,000

Calculated Total Expenses

(rounded)

 

Cost to Raise $100: $25

How many dollars CureSearch for Children's Cancer spends on fundraising to raise each $100 of contributions.

$2,800,000

Calculated Total Contributions

(rounded)

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources

 

Financial Documents

Entity Document Type Tax ID
CureSearch for Children's Cancer IRS Form 990 95-4132414
CureSearch for Children's Cancer Audited Financial Statements 95-4132414
Entity: CureSearch for Children's Cancer
Document Type: IRS Form 990
Tax ID: 95-4132414
Entity: CureSearch for Children's Cancer
Document Type: Audited Financial Statements
Tax ID: 95-4132414

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
CureSearch for Children's Cancer
meets governance benchmarks.
 
CureSearch for Children's Cancer
does not meet transparency benchmarks.
Transparency
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy Opt-Out Policy  

  Name Title Compensation
1 Kay Koehler CEO $380,471
2 Katharine Burke COO/VP Finance $227,768
3 Tiffani Copeland Senior VP, Development & Communications $192,100
1
Name: Kay Koehler
Title: CEO
Compensation: $380,471
2
Name: Katharine Burke
Title: COO/VP Finance
Compensation: $227,768
3
Name: Tiffani Copeland
Title: Senior VP, Development & Communications
Compensation: $192,100

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

According to the CureSearch for Children's Cancer audit of December 31, 2021 (Note 5, Government Grants):

"CureSearch applied for and received funds in the amount of $277,800 under the Paycheck Protection Program (PPP) which was created by the U.S. Federal Government as a result of the coronavirus pandemic. The proceeds were considered a forgivable loan, assuming certain qualified expenses, primarily payroll related expenses, were incurred during a period of eight-weeks to 24-weeks, commencing on the date of the loan agreement (April 20, 2020). Any portion of this loan that did not qualify for forgiveness was subject to an interest rate of 1%. The original loan document required monthly principal installments plus interest over an eighteen-month period commencing on November 20, 2020 with a maturity date of April 20, 2022. However, the beginning date of the repayment of principal period was extended until 10 months after the end of the period of eight-weeks to 24-weeks. As of December 31, 2020, this was recorded as deferred revenue, non-current on the [audited] statements of financial position. CureSearch applied for and received 100% forgiveness of the PPP loan on August 20, 2021, and therefore, this forgiveness has been recognized as government grant revenue during the year ended December 31, 2021.

"In February 2021, CureSearch once again applied for and received additional funds in the amount of $277,800 under the Small Business Administration's (SBA) PPP. The proceeds were considered a forgivable loan, assuming certain qualified expenses, primarily payroll related expenses, were incurred during either a period of eight-weeks to 24-weeks, commencing on the date of the loan agreement (February 9, 2021). ... CureSearch applied for and received 100% forgiveness of the PPP loan on November 24, 2021, and therefore, this forgiveness has been recognized as government grant revenue during the year ended December 31, 2021."

According to the CureSearch for Children's Cancer audit of December 31, 2021 (Note 11, Other Matters, Investment Risk):

"CureSearch invests in a professionally managed portfolio that may contain corporate bonds, mutual funds, money market funds and other investments. Such investments are exposed to various risks such as interest rate, market, and credit. Due to the level of risk associated with such investments and the level of uncertainty related to changes in the value of such investments, it is at least reasonably possible that changes in risks in the near term could materially affect investment balances and the amounts reported in the [audited] financial statements."


According to the CureSearch for Children's Cancer audit of December 31, 2021 (Note 11, Other Matters, National Health Emergency):

"In March 2020, the President of the United States declared a national emergency due to a viral pandemic. The declaration of the national emergency and similar declarations made by various states, and the outbreak of the virus itself, have had far reaching social, economic and financial impacts on the United States. The pandemic continues and at this time [May 25, 2022], the impact on the operations and financial status of CureSearch cannot be determined."


Related Articles

No related articles found